BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15725701)

  • 1. Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors.
    Makishima M
    J Pharmacol Sci; 2005 Feb; 97(2):177-83. PubMed ID: 15725701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
    Redinger RN
    Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acid regulation of gene expression: roles of nuclear hormone receptors.
    Chiang JY
    Endocr Rev; 2002 Aug; 23(4):443-63. PubMed ID: 12202460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?
    Ory DS
    Circ Res; 2004 Oct; 95(7):660-70. PubMed ID: 15459087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.
    Edwards PA; Kast HR; Anisfeld AM
    J Lipid Res; 2002 Jan; 43(1):2-12. PubMed ID: 11792716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xol INXS: role of the liver X and the farnesol X receptors.
    Fayard E; Schoonjans K; Auwerx J
    Curr Opin Lipidol; 2001 Apr; 12(2):113-20. PubMed ID: 11264982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.
    Millatt LJ; Bocher V; Fruchart JC; Staels B
    Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.
    Niesor EJ; Flach J; Lopes-Antoni I; Perez A; Bentzen CL
    Curr Pharm Des; 2001 Mar; 7(4):231-59. PubMed ID: 11254888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-activated transcription factors control bile acid glucuronidation.
    Barbier O; Trottier J; Kaeding J; Caron P; Verreault M
    Mol Cell Biochem; 2009 Jun; 326(1-2):3-8. PubMed ID: 19130183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear receptors and cholesterol metabolism in the intestine.
    Moschetta A
    Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear receptors in cholesterol catabolism: molecular biology of the enterohepatic circulation of bile salts and its role in cholesterol homeostasis.
    Redinger RN
    J Lab Clin Med; 2003 Jul; 142(1):7-20. PubMed ID: 12878981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR.
    Liddle C; Goodwin B
    Semin Liver Dis; 2002; 22(2):115-22. PubMed ID: 12016543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
    Deng R; Yang D; Yang J; Yan B
    J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulation of lipid metabolism by the orphan nuclear receptors].
    Lobaccaro JM; Repa JJ; Lu TT; Caira F; Henry-Berger J; Volle DH; Mangelsdorf DJ
    Ann Endocrinol (Paris); 2001 Jun; 62(3):239-47. PubMed ID: 11458177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice.
    Uppal H; Saini SP; Moschetta A; Mu Y; Zhou J; Gong H; Zhai Y; Ren S; Michalopoulos GK; Mangelsdorf DJ; Xie W
    Hepatology; 2007 Feb; 45(2):422-32. PubMed ID: 17256725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptor: a cardinal target for atherosclerosis and beyond.
    Parikh M; Patel K; Soni S; Gandhi T
    J Atheroscler Thromb; 2014; 21(6):519-31. PubMed ID: 24695022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of LXRalpha signaling by vitamin D receptor: possible role of VDR in bile acid synthesis.
    Jiang W; Miyamoto T; Kakizawa T; Nishio SI; Oiwa A; Takeda T; Suzuki S; Hashizume K
    Biochem Biophys Res Commun; 2006 Dec; 351(1):176-84. PubMed ID: 17054913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity.
    Ourlin JC; Lasserre F; Pineau T; Fabre JM; Sa-Cunha A; Maurel P; Vilarem MJ; Pascussi JM
    Mol Endocrinol; 2003 Sep; 17(9):1693-703. PubMed ID: 12805410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coming of age of our understanding of the enterohepatic circulation of bile salts.
    Redinger RN
    Am J Surg; 2003 Feb; 185(2):168-72. PubMed ID: 12559450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.
    de Boer JF; Schonewille M; Boesjes M; Wolters H; Bloks VW; Bos T; van Dijk TH; Jurdzinski A; Boverhof R; Wolters JC; Kuivenhoven JA; van Deursen JM; Oude Elferink RPJ; Moschetta A; Kremoser C; Verkade HJ; Kuipers F; Groen AK
    Gastroenterology; 2017 Apr; 152(5):1126-1138.e6. PubMed ID: 28065787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.